首页> 外文期刊>Control Systems, IEEE >Magnetic Navigation Control of Microagents in the Vascular Network: Challenges and Strategies for Endovascular Magnetic Navigation Control of Microscale Drug Delivery Carriers
【24h】

Magnetic Navigation Control of Microagents in the Vascular Network: Challenges and Strategies for Endovascular Magnetic Navigation Control of Microscale Drug Delivery Carriers

机译:血管网络中微剂的磁导航控制:微型药物输送载体的血管内磁导航控制的挑战和策略

获取原文
获取原文并翻译 | 示例

摘要

Although navigation control has been applied in a multitude of environments, relatively little is known about the challenges and issues of navigation control in the vascular network. In an adult human, the vascular network consists of nearly 100,000 km of blood vessels, with diameters ranging from a few millimeters in the artery to just a few micrometers in the capillaries, and blood flow rates ranging from a few tens of centimeters per second to a few millimeters per second. Although vascular networks present great challenges, due to various environmental conditions, they are of special interest in medical microrobotics since they allow navigable agents to be delivered anywhere within the body. Controlled endovascular navigation would allow targeted surgical, diagnostic, and therapeutic interventions. In cancer therapy, for instance, although many of the most deadly cancers are initially located in a single region, modern therapies such as chemotherapy continue to inject excessive amounts of toxic agents thecirculate systematically throughout the vascular network. In general, only a tiny fraction of the drug reaches the treatment region [1]. Even the level of targeting achieved by agents with special coatings to enhance tumor cell specificity is far from optimal when they are injected systematically in the vascular network. Since the therapeutics do not discriminate between cancerous and healthy cells, systemic circulation of these agents must be avoided to eliminate, or at least minimize, secondary toxicity that affects healthy organs.
机译:尽管导航控制已应用于多种环境,但对血管网络中导航控制的挑战和问题知之甚少。在成年人中,血管网络由近100,000公里的血管组成,直径范围从动脉中的几毫米到毛细血管中的几微米,血液流速从每秒几十厘米到每秒几毫米。尽管由于各种环境条件,血管网络面临巨大挑战,但它们在医学微机器人领域特别受关注,因为它们可以将通航药物输送到体内任何地方。受控的血管内导航将允许有针对性的手术,诊断和治疗干预。例如,在癌症治疗中,尽管许多最致命的癌症最初都位于单个区域,但是现代疗法(如化学疗法)继续注入过量的有毒物质,这些有毒物质在整个血管网络中系统地循环。通常,只有一小部分药物到达治疗区域[1]。当系统地将它们注射到血管网络中时,甚至用具有特殊涂层的药物达到增强肿瘤细胞特异性的靶向水平也远非最佳。由于治疗剂不能区分癌细胞和健康细胞,因此必须避免这些药物的全身循环,以消除或至少最小化影响健康器官的继发性毒性。

著录项

  • 来源
    《Control Systems, IEEE》 |2013年第6期|119-134|共16页
  • 作者

    Martel S.;

  • 作者单位

    Polytech. Montreal, Univ. de Montreal, Montréal, QC, Canada|c|;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号